SS
COLL icon

Sunbelt Securities’s Collegium Pharmaceutical COLL Stock Holding History

Sunbelt Securities’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$496 Hold
15
– – ﹤0.01% 2294
2025
Q4 		$694 Hold
15
– – ﹤0.01% 2157
2025
Q3 		$525 Buy
+15
New +$521 ﹤0.01% 2212

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Sunbelt Securities's COLL Position: Q1 2026 in Review

Sunbelt Securities held its Collegium Pharmaceutical (COLL) position steady in Q1 2026 at 15 shares worth $496. The position accounts for ﹤0.01% of the portfolio, ranked #2294.

Sunbelt Securities first reported a position in COLL in Q3 2025 and has held it in 3 quarters since. The position peaked at $694 in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Sunbelt Securities held 15 shares of Collegium Pharmaceutical worth $496 as of Q1 2026.
  • Sunbelt Securities left its Collegium Pharmaceutical share count unchanged in Q1 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2294 holding.
  • Sunbelt Securities first reported a position in Collegium Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Collegium Pharmaceutical position peaked at $694 in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.